Literature DB >> 10486304

Metallothionein and apoptosis during differentiation of myoblasts to myotubes: protection against free radical toxicity.

M D Apostolova1, I A Ivanova, M G Cherian.   

Abstract

The changes in subcellular localization of metallothionein (MT) during differentiation were studied in two muscle cell lines, L6 and H9C2, myoblasts in order to understand the nuclear presence of MT and its antiapoptotic property. In myoblasts, MT and zinc were localized mainly in the cytoplasm but were translocated into the nucleus of newly formed myotubes during early stage of differentiation, which was initiated by lowering FBS from 10% to 1%. In fully differentiated myotubes, metallothionein content was decreased with a cytoplasmic localization. These changes in subcellular localization of MT and Zn were accompanied by increased apoptosis in myotubes. The changes in the apoptosis at different stages of differentiation were measured by both DNA ladder formation and TUNEL technique. The results also show that the apoptosis may be initiated by free radical generation and may be accompanied by p53 expression. The H9C2 cells contained high levels of MT, differentiated slowly, and had low incidence of apoptotic bodies compared to L6 cell line. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486304     DOI: 10.1006/taap.1999.8755

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

1.  Influence of metallothionein-1 localization on its function.

Authors:  M Levadoux-Martin; J E Hesketh; J H Beattie; H M Wallace
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

2.  Alterations in mRNA expression and protein products following spinal cord injury in humans.

Authors:  Maria L Urso; Yi-Wen Chen; Angus G Scrimgeour; Patrick C Lee; K Francis Lee; Priscilla M Clarkson
Journal:  J Physiol       Date:  2007-01-11       Impact factor: 5.182

3.  Zinc metallothionein imported into liver mitochondria modulates respiration.

Authors:  B Ye; W Maret; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

4.  Prognostic significance of metallothionein expression in renal cell carcinoma.

Authors:  Dionisios Mitropoulos; Aspasia Kyroudi-Voulgari; Stamatis Theocharis; Efraim Serafetinides; Epaminondas Moraitis; Anastasios Zervas; Christos Kittas
Journal:  World J Surg Oncol       Date:  2005-01-17       Impact factor: 2.754

5.  Metallothionein Gene Family in the Sea Urchin Paracentrotus lividus: Gene Structure, Differential Expression and Phylogenetic Analysis.

Authors:  Maria Antonietta Ragusa; Aldo Nicosia; Salvatore Costa; Angela Cuttitta; Fabrizio Gianguzza
Journal:  Int J Mol Sci       Date:  2017-04-12       Impact factor: 5.923

6.  Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells.

Authors:  Juan Martín Arriaga; Alicia Inés Bravo; José Mordoh; Michele Bianchini
Journal:  Oncol Rep       Date:  2017-04-03       Impact factor: 3.906

7.  Metal- and Affinity-Specific Dual Labeling of Cysteine-Rich Proteins for Identification of Metal-Binding Sites.

Authors:  Manuel David Peris-Díaz; Roman Guran; Ondrej Zitka; Vojtech Adam; Artur Krężel
Journal:  Anal Chem       Date:  2020-09-10       Impact factor: 6.986

8.  Mass Spectrometry-Based Structural Analysis of Cysteine-Rich Metal-Binding Sites in Proteins with MetaOdysseus R Software.

Authors:  Manuel David Peris-Díaz; Roman Guran; Ondrej Zitka; Vojtech Adam; Artur Krężel
Journal:  J Proteome Res       Date:  2020-09-28       Impact factor: 4.466

9.  An Integrated Mass Spectrometry and Molecular Dynamics Simulations Approach Reveals the Spatial Organization Impact of Metal-Binding Sites on the Stability of Metal-Depleted Metallothionein-2 Species.

Authors:  Manuel David Peris-Díaz; Roman Guran; Carmen Domene; Vivian de Los Rios; Ondrej Zitka; Vojtech Adam; Artur Krężel
Journal:  J Am Chem Soc       Date:  2021-09-03       Impact factor: 15.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.